Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.

Yeh I, von Deimling A, Bastian BC.

J Natl Cancer Inst. 2013 Jun 19;105(12):917-9. doi: 10.1093/jnci/djt119. Epub 2013 May 20.

2.

Polyclonality of BRAF mutations in acquired melanocytic nevi.

Lin J, Takata M, Murata H, Goto Y, Kido K, Ferrone S, Saida T.

J Natl Cancer Inst. 2009 Oct 21;101(20):1423-7. doi: 10.1093/jnci/djp309. Epub 2009 Sep 14.

3.

Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.

Karram S, Novy M, Saroufim M, Loya A, Taraif S, Houreih MA, Rauscher B, Habib RH, Oberkanins C, Khalifeh I.

Am J Dermatopathol. 2013 Jun;35(4):412-8. doi: 10.1097/DAD.0b013e31826db181.

PMID:
23051629
4.

BRAF mutations are common somatic events in melanocytic nevi.

Kumar R, Angelini S, Snellman E, Hemminki K.

J Invest Dermatol. 2004 Feb;122(2):342-8.

5.

Melanocytic nevi and melanoma: unraveling a complex relationship.

Damsky WE, Bosenberg M.

Oncogene. 2017 Oct 19;36(42):5771-5792. doi: 10.1038/onc.2017.189. Epub 2017 Jun 12. Review.

PMID:
28604751
6.

Allelotyping, microsatellite instability, and BRAF mutation analyses in common and atypical melanocytic nevi and primary cutaneous melanomas.

Uribe P, Wistuba II, Gonzalez S.

Am J Dermatopathol. 2009 Jun;31(4):354-63. doi: 10.1097/DAD.0b013e318185d205.

PMID:
19461239
7.

Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.

Wu D, Wang M, Wang X, Yin N, Song T, Li H, Yu J, Wang DM, Zhao Z.

Am J Dermatopathol. 2011 Jun;33(4):341-4. doi: 10.1097/DAD.0b013e3181fb5bc7.

PMID:
21430505
8.

BRAF and NRAS mutations in melanoma and melanocytic nevi.

Poynter JN, Elder JT, Fullen DR, Nair RP, Soengas MS, Johnson TM, Redman B, Thomas NE, Gruber SB.

Melanoma Res. 2006 Aug;16(4):267-73.

PMID:
16845322
9.

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation.

Venesio T, Chiorino G, Balsamo A, Zaccagna A, Petti C, Scatolini M, Pisacane A, Sarotto I, Picciotto F, Risio M.

Mod Pathol. 2008 Jun;21(6):716-26. doi: 10.1038/modpathol.2008.41. Epub 2008 Apr 11.

10.

NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.

Tschandl P, Berghoff AS, Preusser M, Burgstaller-Muehlbacher S, Pehamberger H, Okamoto I, Kittler H.

PLoS One. 2013 Jul 8;8(7):e69639. doi: 10.1371/journal.pone.0069639. Print 2013.

11.

BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.

Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, Grunwaldt LJ, Reyes-Múgica M.

Pediatr Dev Pathol. 2015 Jan-Feb;18(1):1-9. doi: 10.2350/14-10-1566-OA.1. Epub 2014 Dec 9.

PMID:
25490715
12.

Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.

Wu J, Rosenbaum E, Begum S, Westra WH.

Am J Dermatopathol. 2007 Dec;29(6):534-7.

PMID:
18032947
13.

Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.

Tseng D, Kim J, Warrick A, Nelson D, Pukay M, Beadling C, Heinrich M, Selim MA, Corless CL, Nelson K.

J Am Acad Dermatol. 2014 Aug;71(2):229-36. doi: 10.1016/j.jaad.2014.03.033. Epub 2014 May 17.

14.

BRAF and NRAS mutations in spitzoid melanocytic lesions.

Fullen DR, Poynter JN, Lowe L, Su LD, Elder JT, Nair RP, Johnson TM, Gruber SB.

Mod Pathol. 2006 Oct;19(10):1324-32. Epub 2006 Jun 23.

15.

RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis.

Dadzie OE, Yang S, Emley A, Keady M, Bhawan J, Mahalingam M.

Br J Dermatol. 2009 Feb;160(2):368-75. doi: 10.1111/j.1365-2133.2008.08887.x. Epub 2008 Oct 20.

PMID:
18945298
16.

Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi.

Uribe P, Andrade L, Gonzalez S.

J Invest Dermatol. 2006 Jan;126(1):161-6.

17.

Genetic alterations in melanocytic tumors.

Takata M, Saida T.

J Dermatol Sci. 2006 Jul;43(1):1-10. Review.

PMID:
16750612
18.

Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.

Mochel MC, Hammond MR, Frederick DT, Alora-Palli MB, Piris A, Flaherty KT, Hoang MP.

J Am Acad Dermatol. 2015 Sep;73(3):491-9.e2. doi: 10.1016/j.jaad.2015.06.006. Epub 2015 Jul 16.

PMID:
26190239
19.

Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.

Takata M, Murata H, Saida T.

Pigment Cell Melanoma Res. 2010 Feb;23(1):64-71. doi: 10.1111/j.1755-148X.2009.00645.x. Epub 2009 Sep 25. Review.

PMID:
19788535
20.

T1799A BRAF mutations in conjunctival melanocytic lesions.

Goldenberg-Cohen N, Cohen Y, Rosenbaum E, Herscovici Z, Chowers I, Weinberger D, Pe'er J, Sidransky D.

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3027-30.

PMID:
16123397

Supplemental Content

Support Center